Apligraf
Ended Awarded
- Contract number
- SPE2D626F2025
- Awardee
-
Organogenesis Inc. UEI VKK3WXM4RCZ7
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $2,480
Award facts
- Contract value 100% obligated
- $2,479.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Full and Open Competition after exclusion of sources · 65 offers Multiple Award, Fair Opportunity
- Pricing
- Fixed Price with Economic Price Adjustment
- Place of performance
- Canton, MA 02021, USA
Award details come from SAM.gov/FPDS.
About this award
Organogenesis Inc., a regenerative medicine company based in Canton, Massachusetts, received a delivery order for APLIGRAF from the Defense Logistics Agency (DLA) Medical Supply Chain on October 15, 2025. This fixed-price contract with economic price adjustment carries a ceiling value of $2,479.90 and is scheduled for completion by October 20, 2025. The award was made without any set-aside designation, indicating Organogenesis competed as a standard commercial vendor. APLIGRAF is an advanced skin substitute product used for wound care and tissue regeneration, supporting the DLA's mission to provide critical medical supplies to military healthcare systems.
This delivery order is issued under one of Organogenesis's larger indefinite delivery vehicles, reflecting the company's established position as a key supplier of regenerative medicine solutions to federal healthcare agencies. Organogenesis maintains significant contract relationships with both the DLA and the Department of Veterans Affairs, including a $49.5 million multiple-award Indefinite Delivery Contract with DLA Troop Support Medical running through June 2026 and a $25 million single-award Indefinite Delivery Contract with VA Headquarters for Surgical Implant Next Generation products. These ongoing relationships enable the company to provide comprehensive advanced wound care and tissue regeneration products to support medical treatments for military personnel and veterans.
Quick answers
Who was awarded contract SPE2D626F2025?
SPE2D626F2025 was awarded to Organogenesis Inc. by Medical Supply Chain (Troop Support) on October 15, 2025.
How much is contract SPE2D626F2025 worth?
The government has obligated $2,480 on SPE2D626F2025.
Is contract SPE2D626F2025 an order under another contract?
Yes. SPE2D626F2025 is a delivery order under SPE2DE21D0005, an indefinite delivery contract.
Was contract SPE2D626F2025 competed?
The extent of competition for SPE2D626F2025 was full and open competition after exclusion of sources. The government received 65 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award